Anti-eGFP Nanobody (VHH), Recombinant, Purified

Anti-eGFP Nanobody (VHH), Recombinant, Purified

Catalog #: EG-NB-6XZF
$355.00
View Cart
3D Structure — Nanobody–Epitope Complex
Loading 3D structure…
anti-eGFP nanobody complex
PDB 6XZF
nanobody (VHH)   antigen   epitope (40)
Drag to rotate · scroll to zoom

Interactive model of the VHH bound to its structural epitope on eGFP (from experimental complex PDB 6XZF). Nanobody in blue, epitope contact residues in red. For research visualization.

Product Description
Product NameAnti-eGFP Nanobody (VHH), Recombinant, Purified
DescriptionA purified, engineered single-domain antibody (VHH / nanobody) against eGFP, for research applications including detection, capture and imaging.
Target / SpecificityeGFP
SequenceThis nanobody is an engineered variant based on PDB 6XZF, with higher affinity and stability than the original published sequence.
FormatPurified recombinant single-domain antibody (VHH / nanobody), carrier-free
Tag & ExpressionC-terminal 6×His tag; secreted from HEK293 cells and purified by one-step IMAC from the culture medium.
Molecular Weight~14 kDa (single VHH domain + His6; ~1/10 the size of a conventional IgG)
Purity>90% by SDS-PAGE
Quantity100 µg
FormulationPBS with 50% glycerol (carrier-free); 0.02% sodium azide
ApplicationsELISA, Western blot (WB), immunofluorescence (IF), immunoprecipitation (IP), affinity capture
Structural EpitopeEpitope mapped from the experimental VHH–antigen complex (PDB 6XZF); 40 antigen contact residues within 5 Å. An interactive 3D complex model is shown on this page.
StorageStore at -20°C; avoid repeated freeze-thaw. Stable 1 year.
AdvantagesNanobodies are the smallest functional antibody fragments: exceptional thermal and chemical stability, single-domain, high-yield recombinant production, and access to cryptic epitopes and dense tissue that conventional antibodies cannot reach.
Product Documents
DatasheetEG-NB-6XZF Product Datasheet
Download PDF
Related Products